Patient voices take center stage in haemophilia a treatment decisions

NCT ID NCT07653139

Not yet recruiting Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study asks adults with haemophilia A in Germany to complete an online survey about their preferences for preventive treatments. Participants choose between hypothetical treatment options that vary in effectiveness, safety, and how they are given. The goal is to understand what trade-offs patients are willing to make, so that future treatments and health policies can better reflect patient values.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help shape treatment guidelines and health policy to better match what patients truly value.
What could go wrong: This is a survey-based study, not a treatment trial. It gathers opinions, not clinical outcomes, so its impact depends on how well preferences translate into real-world decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAEMOPHILIA A

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Novo Nordisk Investigational Site

Mainz, Gonsenheim, 55124, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.